Thomas George Larson

Array ( [id] => 4322989 [patent_doc_number] => 06312602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Peptide-containing compositions, and methods of making and using same' [patent_app_type] => 1 [patent_app_number] => 9/212174 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 9222 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312602.pdf [firstpage_image] =>[orig_patent_app_number] => 212174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346092 [patent_doc_number] => 06284741 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Method for the prophylaxis and/or treatment of proliferative and /or inflammatory skin disorders' [patent_app_type] => 1 [patent_app_number] => 9/199926 [patent_app_country] => US [patent_app_date] => 1998-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26400 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284741.pdf [firstpage_image] =>[orig_patent_app_number] => 199926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4149178 [patent_doc_number] => 06113816 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes' [patent_app_type] => 1 [patent_app_number] => 9/182416 [patent_app_country] => US [patent_app_date] => 1998-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3970 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113816.pdf [firstpage_image] =>[orig_patent_app_number] => 182416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4273818 [patent_doc_number] => 06280978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Methods and compositions for use in spliceosome mediated RNA trans-splicing' [patent_app_type] => 1 [patent_app_number] => 9/158863 [patent_app_country] => US [patent_app_date] => 1998-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 31 [patent_no_of_words] => 19743 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280978.pdf [firstpage_image] =>[orig_patent_app_number] => 158863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406472 [patent_doc_number] => 06238917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Asymmetric hammerhead ribozymes' [patent_app_type] => 1 [patent_app_number] => 9/156828 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18407 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/238/06238917.pdf [firstpage_image] =>[orig_patent_app_number] => 156828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411845 [patent_doc_number] => 06265560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Human Ste20-like stress activated serine/threonine kinase' [patent_app_type] => 1 [patent_app_number] => 9/152406 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23832 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265560.pdf [firstpage_image] =>[orig_patent_app_number] => 152406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292595 [patent_doc_number] => 06183996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Nucleotide sequence encoding carbamoyl phosphate synthetase II' [patent_app_type] => 1 [patent_app_number] => 9/150741 [patent_app_country] => US [patent_app_date] => 1998-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7323 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183996.pdf [firstpage_image] =>[orig_patent_app_number] => 150741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093205 [patent_doc_number] => 06096522 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Antibody and method for detecting the human homolog of MAD2' [patent_app_type] => 1 [patent_app_number] => 9/145868 [patent_app_country] => US [patent_app_date] => 1998-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 31 [patent_no_of_words] => 11701 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096522.pdf [firstpage_image] =>[orig_patent_app_number] => 145868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129270 [patent_doc_number] => 06146829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Gapped 2\' modified oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/144611 [patent_app_country] => US [patent_app_date] => 1998-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14248 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146829.pdf [firstpage_image] =>[orig_patent_app_number] => 144611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4236429 [patent_doc_number] => 06090626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Antisense oligonucleotide modulation of raf gene expression' [patent_app_type] => 1 [patent_app_number] => 9/143214 [patent_app_country] => US [patent_app_date] => 1998-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12318 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090626.pdf [firstpage_image] =>[orig_patent_app_number] => 143214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4170977 [patent_doc_number] => 06083702 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Methods and compositions for use in spliceosome mediated RNA trans-splicing' [patent_app_type] => 1 [patent_app_number] => 9/133717 [patent_app_country] => US [patent_app_date] => 1998-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 14757 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083702.pdf [firstpage_image] =>[orig_patent_app_number] => 133717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4261472 [patent_doc_number] => 06204326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'PNA combinatorial libraries and improved methods of synthesis' [patent_app_type] => 1 [patent_app_number] => 9/131270 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24516 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204326.pdf [firstpage_image] =>[orig_patent_app_number] => 131270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4358585 [patent_doc_number] => 06174870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Antisense oligonucleotide inhibition of papillomavirus' [patent_app_type] => 1 [patent_app_number] => 9/130426 [patent_app_country] => US [patent_app_date] => 1998-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 11049 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174870.pdf [firstpage_image] =>[orig_patent_app_number] => 130426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099912 [patent_doc_number] => 06100028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'DNA polymerase extension assay' [patent_app_type] => 1 [patent_app_number] => 8/973139 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5300 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100028.pdf [firstpage_image] =>[orig_patent_app_number] => 973139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4291979 [patent_doc_number] => 06183959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Method for target site selection and discovery' [patent_app_type] => 1 [patent_app_number] => 9/112086 [patent_app_country] => US [patent_app_date] => 1998-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 16142 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183959.pdf [firstpage_image] =>[orig_patent_app_number] => 112086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4385463 [patent_doc_number] => 06277981 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Method for design and selection of efficacious antisense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/109663 [patent_app_country] => US [patent_app_date] => 1998-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17442 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277981.pdf [firstpage_image] =>[orig_patent_app_number] => 109663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248790 [patent_doc_number] => 06221849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'DNA methyltransferase genomic sequences and antisense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/103875 [patent_app_country] => US [patent_app_date] => 1998-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 10173 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221849.pdf [firstpage_image] =>[orig_patent_app_number] => 103875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234519 [patent_doc_number] => 06117847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Oligonucleotides for enhanced modulation of protein kinase C expression' [patent_app_type] => 1 [patent_app_number] => 9/094714 [patent_app_country] => US [patent_app_date] => 1998-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13760 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117847.pdf [firstpage_image] =>[orig_patent_app_number] => 094714 [rel_patent_id] =>[rel_patent_doc_number] =>)